Published in J Virol on February 01, 1991
The causal relation between human papillomavirus and cervical cancer. J Clin Pathol (2002) 14.73
Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol (1995) 3.57
Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice. J Virol (1994) 2.73
Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer. J Clin Microbiol (1992) 2.60
Transient replication of human papillomavirus DNAs. J Virol (1992) 2.43
Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. Proc Natl Acad Sci U S A (1992) 2.30
Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridisation. J Clin Pathol (1991) 2.06
Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol (2002) 2.03
Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J Clin Microbiol (1999) 1.95
Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers. J Virol (2003) 1.79
The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. EMBO J (1994) 1.71
Coexistence of episomal and integrated HPV16 DNA in squamous cell carcinoma of the cervix. J Clin Pathol (1994) 1.70
Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3. J Natl Cancer Inst (2009) 1.65
Temporal usage of multiple promoters during the life cycle of human papillomavirus type 31b. J Virol (1998) 1.37
Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas. J Clin Microbiol (2006) 1.36
Human papillomavirus 16 E7 protein is associated with the nuclear matrix. Proc Natl Acad Sci U S A (1991) 1.35
Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response. Proc Natl Acad Sci U S A (2006) 1.31
Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions. J Virol (1994) 1.30
High viral loads of human papillomavirus predict risk of invasive cervical carcinoma. Br J Cancer (2005) 1.29
Human papillomavirus type 31b E1 and E2 transcript expression correlates with vegetative viral genome amplification. Virology (1998) 1.28
CpG methylation directly inhibits binding of the human papillomavirus type 16 E2 protein to specific DNA sequences. J Virol (1996) 1.26
YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity. J Virol (1996) 1.24
The molecular genetics of cervical carcinoma. Br J Cancer (1999) 1.24
Stability of the human papillomavirus type 18 E2 protein is regulated by a proteasome degradation pathway through its amino-terminal transactivation domain. J Virol (2001) 1.19
Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ Hybridization. Infect Agent Cancer (2012) 1.17
The integration of HPV-18 DNA in cervical carcinoma. Mol Pathol (1999) 1.17
Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology. J Clin Pathol (2006) 1.16
Human papillomaviruses and cervical neoplasia. I. Classification, virology, pathology, and epidemiology. J Clin Pathol (1994) 1.15
Propagation of infectious human papillomavirus type 16 by using an adenovirus and Cre/LoxP mechanism. Proc Natl Acad Sci U S A (2004) 1.15
Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1. EMBO J (2002) 1.14
The E5 proteins. Virology (2013) 1.11
HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress. Future Virol (2011) 1.10
Human papillomavirus molecular biology and disease association. Rev Med Virol (2015) 1.09
The characteristics of human papillomavirus DNA in head and neck cancers and papillomas. J Clin Pathol (2005) 1.09
T-cell responses to human papillomavirus type 16 among women with different grades of cervical neoplasia. Br J Cancer (2005) 1.08
Transforming growth factor beta1 induces differentiation in human papillomavirus-positive keratinocytes. J Virol (1996) 1.08
Analysis of HPV16, 18, 31, and 35 DNA in pre-invasive and invasive lesions of the uterine cervix. J Clin Pathol (1997) 1.06
Human papillomavirus type 33 in a tonsillar carcinoma generates its putative E7 mRNA via two E6* transcript species which are terminated at different early region poly(A) sites. J Virol (1992) 1.06
Rapid and sensitive detection of physical status of human papillomavirus type 16 DNA by quantitative real-time PCR. J Clin Microbiol (2002) 1.04
Equivocal p16 immunostaining in squamous cell carcinoma of the head and neck: staining patterns are suggestive of HPV status. Head Neck Pathol (2012) 1.04
The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification. J Virol (2010) 1.02
E1 empty set E4 protein of human papillomavirus type 16 associates with mitochondria. J Virol (2004) 0.99
Genomic landscape of human papillomavirus-associated cancers. Clin Cancer Res (2015) 0.99
Analysis by multiplex PCR of the physical status of human papillomavirus type 16 DNA in cervical cancers. J Clin Microbiol (1999) 0.96
Development of a cellular assay system to study the genome replication of high- and low-risk mucosal and cutaneous human papillomaviruses. J Virol (2011) 0.96
Human papillomavirus type 16 status in cervical carcinoma cell DNA assayed by multiplex PCR. J Clin Microbiol (2003) 0.94
Recombination-dependent oligomerization of human papillomavirus genomes upon transient DNA replication. J Virol (2013) 0.89
Human papillomavirus mutational insertion: specific marker of circulating tumor DNA in cervical cancer patients. PLoS One (2012) 0.89
HPV associated tumor cells control tumor microenvironment and leukocytosis in experimental models. Immun Inflamm Dis (2014) 0.88
A novel YY1-independent silencer represses the activity of the human papillomavirus type 16 enhancer. J Virol (1998) 0.87
Integration of Epstein-Barr virus into chromosome 6q15 of Burkitt lymphoma cell line (Raji) induces loss of BACH2 expression. Am J Pathol (2004) 0.87
Prevalence, viral load, and physical status of HPV 16 and 18 in cervical adenosquamous carcinoma. Virchows Arch (2009) 0.87
Chromosomal imbalances in four new uterine cervix carcinoma derived cell lines. BMC Cancer (2003) 0.85
The etiologic role of human papillomavirus in penile cancers: a study in Vietnam. Br J Cancer (2013) 0.85
Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology. Oncotarget (2016) 0.85
Small tumor virus genomes are integrated near nuclear matrix attachment regions in transformed cells. J Virol (2001) 0.84
Laboratory techniques in the investigation of human papillomavirus infection. Genitourin Med (1992) 0.84
Analysis of human papillomavirus type 18 load and integration status from low-grade cervical lesion to invasive cervical cancer. J Clin Microbiol (2008) 0.83
Human papillomavirus genotyping and integration in ovarian cancer Saudi patients. Virol J (2013) 0.83
Expression of betapapillomavirus oncogenes increases the number of keratinocytes with stem cell-like properties. J Virol (2013) 0.83
Physical status of human papillomavirus integration in cervical cancer is associated with treatment outcome of the patients treated with radiotherapy. PLoS One (2014) 0.82
Predominance of serum antibodies to synthetic peptide stemming from HPV 18 open reading frame E2 in cervical adenocarcinoma. J Clin Pathol (1992) 0.80
Episomal amplification or chromosomal integration of the viral genome: alternative pathways in hamster polyomavirus-induced lymphomas. J Virol (1995) 0.80
Historical review of the causes of cancer. World J Clin Oncol (2016) 0.79
Novel binding sites for regulatory factors in the human papillomavirus type 18 enhancer and promoter identified by in vivo footprinting. J Virol (1998) 0.79
Use of multiple displacement amplification in the investigation of human papillomavirus physical status. J Clin Pathol (2006) 0.78
Sequence variation analysis of HPV-18 isolates in southwest China. PLoS One (2013) 0.78
Quantitative measurement of human papillomavirus type 16 e5 oncoprotein levels in epithelial cell lines by mass spectrometry. J Virol (2012) 0.78
Relationship between CK19 expression, deregulation of normal keratinocyte differentiation pattern and high risk-human papilloma virus infection in oral and oropharyngeal squamous cell carcinoma. Infect Agent Cancer (2015) 0.77
Antibodies to human papillomavirus type 16 E7 related to clinicopathological data in patients with cervical carcinoma. J Clin Pathol (1995) 0.77
New technologies for cervical cancer screening. Best Pract Res Clin Obstet Gynaecol (2011) 0.77
Stranglehold on the spindle assembly checkpoint: the human papillomavirus E2 protein provokes BUBR1-dependent aneuploidy. Cell Cycle (2015) 0.77
Relation between retinoblastoma and p53 proteins in human papilloma viruses 16/18 positive and negative cancers of the uterine cervix. J Clin Pathol (1997) 0.77
Initial amplification of the HPV18 genome proceeds via two distinct replication mechanisms. Sci Rep (2015) 0.76
Cytokeratin7 and cytokeratin19 expression in high grade cervical intraepithelial neoplasm and squamous cell carcinoma and their possible association in cervical carcinogenesis. Diagn Pathol (2017) 0.76
Chronic oxidative stress increases the integration frequency of foreign DNA and human papillomavirus 16 in human keratinocytes. Am J Cancer Res (2016) 0.75
Differences in serological IgA responses to recombinant baculovirus-derived human papillomavirus E2 protein in the natural history of cervical neoplasia. Br J Cancer (1997) 0.75
Mate-Pair Sequencing as a Powerful Clinical Tool for the Characterization of Cancers with a DNA Viral Etiology. Viruses (2015) 0.75
Next generation sequencing and its applications in HPV-associated cancers. Oncotarget (2016) 0.75
Different Association of Human Papillomavirus 16 Variants with Early and Late Presentation of Cervical Cancer. PLoS One (2016) 0.75
Tetraarsenic oxide-mediated apoptosis in a cervical cancer cell line, SiHa. Cancer Res Treat (2005) 0.75
Diagnosis of genital infection caused by human papillomavirus using in situ hybridisation: the importance of the size of the biopsy specimen. J Clin Pathol (1995) 0.75
Molecular mechanisms of HPV mediated neoplastic progression. Infect Agent Cancer (2016) 0.75
Analysis of The Cancer Genome Atlas sequencing data reveals novel properties of the human papillomavirus 16 genome in head and neck squamous cell carcinoma. Oncotarget (2017) 0.75
Human Papillomavirus (HPV) virion induced cancer and subfertility, two sides of the same coin. Facts Views Vis Obgyn (2017) 0.75
The role of integration in oncogenic progression of HPV-associated cancers. PLoS Pathog (2017) 0.75
Methylation of HPV and a tumor suppressor gene reveals anal cancer and precursor lesions. Oncotarget (2017) 0.75
Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08
A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A (1983) 14.73
Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol (1985) 6.18
The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J Gen Virol (1985) 4.82
Electrophoresis of DNA in agarose gels. Optimizing separations of conformational isomers of double- and single-stranded DNAs. Biochemistry (1977) 4.20
A novel type of human papillomavirus associated with genital neoplasias. Nature (1986) 2.89
Papillomavirus genomes in human cervical tumors: analysis of their transcriptional activity. Proc Natl Acad Sci U S A (1985) 2.48
Oncogenic association of specific human papillomavirus types with cervical neoplasia. J Natl Cancer Inst (1987) 2.45
Sexually transmitted papillomaviral infections. I. The anatomic distribution and pathologic grade of neoplastic lesions associated with different viral types. Am J Obstet Gynecol (1987) 1.97
The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene (1989) 1.94
Molecular analysis of integrated human papillomavirus 16 sequences in the cervical cancer cell line SiHa. Virology (1987) 1.57
A new type of papillomavirus associated with cancer of the uterine cervix. Virology (1987) 1.53
Analysis of individual human papillomavirus types in cervical neoplasia: a possible role for type 18 in rapid progression. Am J Obstet Gynecol (1988) 1.52
Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. Virology (1989) 1.46
Human papillomavirus 16 DNA in cervical cancers and in lymph nodes of cervical cancer patients: a diagnostic marker for early metastases? Int J Cancer (1989) 1.35
Characterization of human papillomavirus type 45, a new type 18-related virus of the genital tract. J Gen Virol (1987) 1.32
Presence of catenated human papillomavirus type 16 episomes in a cervical carcinoma cell line. J Virol (1989) 1.30
Physical state and biological activity of human papillomavirus genomes in precancerous lesions of the female genital tract. J Gen Virol (1988) 1.24
Cloning and partial DNA sequencing of two new human papillomavirus types associated with condylomas and low-grade cervical neoplasia. J Virol (1989) 1.21
Possible prognostic significance of human papillomavirus type in cervical cancer. Gynecol Oncol (1988) 1.18
Plurality of genital human papillomaviruses: characterization of two new types with distinct biological properties. Virology (1987) 1.18
Human papillomavirus type 16 DNA in genital tumours: a pathological and molecular analysis. J Gen Virol (1986) 1.13
Sequence duplication and internal deletion in the integrated human papillomavirus type 16 genome cloned from a cervical carcinoma. J Virol (1988) 1.12
Isolation of a novel human papillomavirus (type 51) from a cervical condyloma. J Virol (1988) 1.09
Human papillomavirus type 52: a new virus associated with cervical neoplasia. J Gen Virol (1988) 1.08
Human papillomavirus genotype as a prognostic indicator in carcinoma of the uterine cervix. Obstet Gynecol (1989) 1.00
Human papillomavirus type 56: a new virus detected in cervical cancers. J Gen Virol (1989) 0.95
Episomal HPV 16 DNA isolated from a cervical carcinoma presents a partial duplication of the early region. Virus Res (1989) 0.90
Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol (1992) 7.14
Protein kinase activity associated with the product of the yeast cell division cycle gene CDC28. Proc Natl Acad Sci U S A (1985) 5.03
Primary structure homology between the product of yeast cell division control gene CDC28 and vertebrate oncogenes. Nature (1984) 4.74
A new enzyme superfamily - the phosphopantetheinyl transferases. Chem Biol (1996) 4.71
Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. N Engl J Med (1995) 3.92
Genital warts and cervical cancer. I. Evidence of an association between subclinical papillomavirus infection and cervical malignancy. Cancer (1982) 2.76
Practicing participatory research in American Indian communities. Am J Clin Nutr (1999) 2.72
The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. N Engl J Med (1991) 2.48
Null mutations in the SNF3 gene of Saccharomyces cerevisiae cause a different phenotype than do previously isolated missense mutations. Mol Cell Biol (1986) 2.30
Enterotoxigenic Bacteroides fragilis: epidemiologic studies of its role as a human diarrhoeal pathogen. J Diarrhoeal Dis Res (1992) 2.23
Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol (1998) 2.21
Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial. J Clin Oncol (2001) 2.16
Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Multiple Sclerosis Collaborative Research Group (MSCRG) Neurology (1998) 2.16
Intestinal reperfusion injury is mediated by IgM and complement. J Appl Physiol (1985) (1999) 2.13
Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations. J Pediatr (1997) 2.07
Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer. Int J Radiat Oncol Biol Phys (1993) 1.99
Sexually transmitted papillomaviral infections. I. The anatomic distribution and pathologic grade of neoplastic lesions associated with different viral types. Am J Obstet Gynecol (1987) 1.97
Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group. Ann Neurol (1998) 1.97
Noncondylomatous cervical wart virus infection. Obstet Gynecol (1980) 1.79
Stress response in infants undergoing cardiac surgery: a randomized study of fentanyl bolus, fentanyl infusion, and fentanyl-midazolam infusion. Anesth Analg (2001) 1.70
Identification of new RNA modifying enzymes by iterative genome search using known modifying enzymes as probes. Nucleic Acids Res (1996) 1.68
Dysregulation of sphingolipid and sterol metabolism by ApoE4 in HIV dementia. Neurology (2004) 1.66
Development of a questionnaire to assess knowledge, attitudes, and behaviors in American Indian children. Am J Clin Nutr (1999) 1.59
A retroperitoneal bronchogenic cyst: a rare cause of a mass in the adrenal region. J Clin Pathol (2001) 1.58
Analysis of individual human papillomavirus types in cervical neoplasia: a possible role for type 18 in rapid progression. Am J Obstet Gynecol (1988) 1.52
Sequence analysis of temperature-sensitive mutations in the Saccharomyces cerevisiae gene CDC28. Mol Cell Biol (1986) 1.52
Second-trimester echogenic bowel and intraamniotic bleeding: association between fetal bowel echogenicity and amniotic fluid spectrophotometry at 410 nm. Am J Obstet Gynecol (1996) 1.51
Oncology Rehabilitation Program at the Ottawa Regional Cancer Centre: program description. CMAJ (1999) 1.51
Multifocal synchronous osteosarcoma: the Scottish Bone Tumour Registry experience. Med Pediatr Oncol (1993) 1.50
Incorporation of radioactive tubulin into microtubules at steady state. Experimental and theoretical analyses of diffusional and directional flux. J Biol Chem (1980) 1.48
Evaluation of the long term outcome of patients with extremity desmoids. Eur J Surg Oncol (2004) 1.48
Value of biopsy in the assessment of a retroperitoneal mass. Surgeon (2006) 1.47
Design of a group-randomized Streptococcus pneumoniae vaccine trial. Control Clin Trials (2001) 1.44
Reduction of corneal astigmatism at cataract surgery. J Cataract Refract Surg (1991) 1.44
Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens. J Clin Microbiol (1997) 1.44
Genital warts and cervical cancer. VII. An improved colposcopic index for differentiating benign papillomaviral infections from high-grade cervical intraepithelial neoplasia. Am J Obstet Gynecol (1985) 1.41
Inhibition of metallo-beta-lactamases by a series of mercaptoacetic acid thiol ester derivatives. Antimicrob Agents Chemother (1997) 1.40
A double-blind, randomized trial of 0.5% podofilox and placebo for the treatment of genital warts in women. Obstet Gynecol (1991) 1.39
Outpatient surgery: same-day formisuicide. JAMA (1986) 1.39
Bacillary angiomatosis of the conjunctiva. Am J Ophthalmol (1994) 1.37
Fetal complications of obstetric cholestasis. Br Med J (1976) 1.37
Role of soy-based, lactose-free formula during treatment of acute diarrhea. Pediatrics (1985) 1.34
Immunogenicity evaluation of a lipidic amino acid-based synthetic peptide vaccine for Chlamydia trachomatis. J Immunol (1993) 1.32
Estimation of body fat from anthropometry and bioelectrical impedance in Native American children. Int J Obes Relat Metab Disord (2000) 1.26
High incidence rates of invasive pneumococcal disease in the White Mountain Apache population. Arch Intern Med (1992) 1.25
Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin. N Engl J Med (1987) 1.25
Rapid detection and typing of herpes simplex virus DNA in clinical specimens by the hybrid capture II signal amplification probe test. J Clin Microbiol (1997) 1.23
Intraoperative radioguided thoracoscopic removal of ectopic parathyroid adenoma. Ann Thorac Surg (2001) 1.21
Building a decision-support system. Leadersh Health Serv (1992) 1.20
Genital warts and cervical cancer. IV. A colposcopic index for differentiating subclinical papillomaviral infection from cervical intraepithelial neoplasia. Am J Obstet Gynecol (1984) 1.20
Subpopulations of Langerhans' cells in cervical neoplasia. Br J Obstet Gynaecol (1987) 1.19
A phase 3, multicenter, open-label, randomized study of abarelix versus leuprolide acetate in men with prostate cancer. Urology (2001) 1.18
Correlation of cellular atypia and human papillomavirus deoxyribonucleic acid sequences in exfoliated cells of the uterine cervix. Obstet Gynecol (1986) 1.16
Genital warts and cervical cancer. III. Subclinical papillomaviral infection and cervical neoplasia are linked by a spectrum of continuous morphologic and biologic change. Cancer (1984) 1.15
A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population. J Infect Dis (1991) 1.14
Directed elongation model for microtubule GTP hydrolysis. Proc Natl Acad Sci U S A (1985) 1.13
International terminology of colposcopy: an updated report from the International Federation for Cervical Pathology and Colposcopy. Obstet Gynecol (2003) 1.13
Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in swab specimens by the Hybrid Capture II and PACE 2 nucleic acid probe tests. Sex Transm Dis (1999) 1.12
Safety and immunogenicity of a Haemophilus influenzae type b conjugate vaccine in a high risk American Indian population. Pediatr Infect Dis J (1991) 1.12
Guidelines for the diagnosis and management of carcinoid tumours. Part 1: the gastrointestinal tract. A statement from a Canadian National Carcinoid Expert Group. Curr Oncol (2006) 1.11
Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children. Pediatr Infect Dis J (1993) 1.08
Prevention of Haemophilus influenzae type b infections in Apache and Navajo children. J Infect Dis (1992) 1.08
Estimation of the indirect effect of Haemophilus influenzae type b conjugate vaccine in an American Indian population. Int J Epidemiol (2000) 1.07
Thromboprophylaxis following caesarean section; hospital protocols are necessary. N Z Med J (2001) 1.06
Ultrasound and hookwire needle placement for localization of a hydrocele of the canal of Nuck. Obstet Gynecol (1995) 1.06
Injuries among the Hopi Indians. A population-based survey. JAMA (1983) 1.06
Twentieth-century survival from osteosarcoma in childhood. Trends from 1933 to 2004. J Bone Joint Surg Br (2007) 1.04
Assay of endotoxin by the hypothermic response of mice. Br J Exp Pathol (1971) 1.04
Myositis ossificans and fibroosseous pseudotumor of digits: a clinicopathological review of 64 cases with emphasis on diagnostic pitfalls. Int J Surg Pathol (2003) 1.02
The measurement of premenstrual mood symptoms. J Affect Disord (1999) 1.02
Body composition assessment in American Indian children. Am J Clin Nutr (1999) 1.01
Inhibition of metallo-beta-lactamases by a series of thiol ester derivatives of mercaptophenylacetic acid. FEMS Microbiol Lett (1997) 1.00
Spatial trypanosomosis management: from data-layers to decision making. Trends Parasitol (2001) 0.99
Delayed posterior dislocation of silicone plate-haptic lenses after neodymium:yag capsulotomy. J Cataract Refract Surg (2000) 0.99
Evaluation of the indirect effects of a pneumococcal vaccine in a community-randomized study. J Biopharm Stat (2006) 0.98
Extraosseous osteosarcoma of the penis. Clin Oncol (R Coll Radiol) (2000) 0.98
Impact of duration in a cardiac rehabilitation program on coronary risk profile and health-related quality of life outcomes. J Cardiopulm Rehabil (2000) 0.98
The Ohio Medicaid Drug Formulary. Ohio Med (1987) 0.97
Polymorphism of DRA among equids. Immunogenetics (1996) 0.96
A significant proportion of patients with osteosarcoma may belong to Li-Fraumeni cancer families. J Bone Joint Surg Br (1992) 0.96
Outcomes with daptomycin versus standard therapy for osteoarticular infections associated with Staphylococcus aureus bacteraemia. J Antimicrob Chemother (2007) 0.96
Action mechanism of Escherichia coli DNA photolyase. I. Formation of the enzyme-substrate complex. J Biol Chem (1987) 0.96
Measuring the incidence of adult community-acquired pneumonia in a Native American community. Epidemiol Infect (2010) 0.95
Toward elimination of Haemophilus influenzae type B carriage and disease among high-risk American Indian children. Am J Public Health (2000) 0.95
Carcinogenic potential of commonly used hernia repair prostheses in an experimental model. Br J Surg (2004) 0.94
Presentation and outcome of primary tumors of the patella. J Knee Surg (2008) 0.94
Invasive pulmonary haemangiomatosis. Br J Dis Chest (1985) 0.94
Obtaining consent for eye donation. Am J Ophthalmol (1987) 0.93
A case of nephrobronchial and colonobronchial fistula presenting as lung abscess. J Urol (1977) 0.93
Differential effects of self-monitoring attention, accuracy, and productivity. J Appl Behav Anal (1993) 0.92
A line scanning confocal fluorescent microscope using a CMOS rolling shutter as an adjustable aperture. J Microsc (2012) 0.92
Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa-2a by intramuscular injection. Cancer (1987) 0.92
Prosthetic reconstruction of the femur for primary bone sarcoma. Int Orthop (1999) 0.92
Assay procedures for the determination of biogenic amines and their metabolites in rat hypothalamus using ion-pairing reversed-phase high-performance liquid chromatography. J Chromatogr (1983) 0.91
Xanthogranulomatous cholecystitis: report of seven cases. Am Surg (1981) 0.91
Cervical extraskeletal Ewing's sarcoma: case report demonstrating radiological features and management. J Laryngol Otol (2007) 0.91
Role of certain virulence factors in a murine model of Staphylococcus aureus arthritis. J Med Microbiol (1997) 0.91
(S)-(-)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine maleate (SIB-1508Y): a novel anti-parkinsonian agent with selectivity for neuronal nicotinic acetylcholine receptors. J Med Chem (1996) 0.90
Cluster and regional influences on suicide in a Southwestern American Indian tribe. Soc Sci Med (2001) 0.90